New RSV vaccine called Arexy approved for people aged 60 and older
Health Canada has authorized the first RSV vaccine for people aged 60 and older.
Doctors have been calling for the vaccine for this group, which is at a higher risk of becoming severely ill from the virus.
Drugmaker GSK says during clinical trials, the drug was 82 percent effective at lowering respiratory tract disease caused by RSV.
In Canada, RSV season usually starts in the fall, and ends in the spring.

Moyer Farms Making $12M Investment
Niagara Falls Going Green for St. Patrick's Day
St. Catharines RIDE Campaign
Davies Challenges Gov't on EV Support
Welland's Plan for Hospital Contribution
New GO Station Coming to Niagara
Most Serious Collisions in Summer: Region
Coach Service Added to Airport